[1] Kumar V,Abbas AK,Aster J.,Robbins J. .2020 .Cotran pathologic basis of disease. Sciences Division;, : .
[2] Onder A,Kapan M,Ulger BV,Oguz A,Turkoglu A,Uslukaya O,INTSURG-D- O .2015 .Gangrenous cholecystitis: mortality and risk factors. Int Surg, 10(00222) : 254-60.
[3] Chang W-C,Sun Y,Wu E-H,Kim SY,Wang ZJ,Huang G- .2016 .CT findings for detecting the presence of gangrenous ischemia in cholecystitis. AJR Am J Roentgenol, 10(2) : 302-9.
[4] Agha RA,Franchi T,Sohrabi C,Mathew G,Kerwan A .2020 .The SCARE 2020 guideline: updating consensus Surgical Case Report (SCARE) guidelines. Int J Surg, 10 : 226-30.
[5] Medina VJ,Martial AM,Chatterjee T. .2023 .Asymptomatic gangrenous acute cholecystitis: A life-threatening condition. Cureus, 10(3) : .
[6] Falor AE,Zobel M,Kaji A,Neville A,Virgilio CD .2012 .Admission variables predictive of gangrenous cholecystitis. Am Surg, 78(10) : 1075-8.
[7] Nikfarjam M,Niumsawatt V,Sethu A,Fink MA,Muralidharan V,Starkey G .2011 .Outcomes of contemporary management of gangrenous and non-gangrenous acute cholecystitis. HPB (Oxford), 00327(8) : 2574-8.
[8] Mok KWJ,Reddy R,Wood F .2014 .Is C-reactive protein a useful adjunct in selecting patients for emergency cholecystectomy by predicting severe/ gangrenous cholecystitis?. Int J Surg, 05(7) : 649-53.
[9] Gomes CA,Soares C,Di Saverio S,Sartelli M,de Souza SPG,Orlandi AS .2019 .Gangrenous cholecystitis in male patients: A study of prevalence and predictive risk factors. Ann Hepatobiliary Pancreat Surg, 23(1) : 34-40.